Clinical Social Workers in Waterville, ME Accepting Medicare

83 Clinical Social Workers found. Showing 1 - 20

Jon Lourens, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136

Rodney G Berger, LCPC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 60 Front St # 10, Waterville, ME 04901 Phone: 207-649-0339    Fax: 207-861-0125

Kaitlyn Boudreau, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136    Fax: 207-660-4529

Nicole Hallett, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 211 Main St, Waterville, ME 04901 Phone: 207-877-3400    Fax: 207-877-3401

Deirdre Finney Boylan, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136    Fax: 207-872-4522

Rebekah J Smith, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 325 Kennedy Memorial Dr Bldg D, Waterville, ME 04901 Phone: 207-616-0499

Ms. Cindy Lou Schumacher, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-660-4549    Fax: 207-660-4929

Mr. Gabriel Pinnette, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 13 Railroad Sq Ste 1, Waterville, ME 04901 Phone: 207-649-9454

Carol L Jollotta, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 60 Front St, Waterville, ME 04901 Phone: 207-314-1949

Molly Bea Benner, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136

Claudia B Hill, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 93 Silver St, Waterville, ME 04901 Phone: 207-873-2330    Fax: 207-873-3795

Heather Elize Carson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136

Dennis James Dix, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136    Fax: 207-872-4522

Lauren S B Hample, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 149 North Street, 3200, Waterville, ME 04901 Phone: 207-861-3500    Fax: 207-861-6201

Patricia Mahoney-rohrl, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136

Gale Adele Davison, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136    Fax: 207-872-4522

Robyn King, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-660-4549    Fax: 207-660-4529

Lisa Hickey, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 Water St, Suite 306, Waterville, ME 04901 Phone: 207-861-3488    Fax: 207-861-3470

Judith Ann St. Hilaire, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136    Fax: 207-872-4522

Stephanie Ann Oliphant, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 67 Eustis Pkwy, Waterville, ME 04901 Phone: 207-873-2136    Fax: 207-872-4522

News Archive

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Janssen Research & Development, LLC announced today that the U.S. Food and Drug Administration has granted Priority Review for the New Drug Application (NDA) for YONDELIS (trabectedin) to treat patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

Dr. Paul Fidel, the Carl Baldridge Professor and Associate Dean for Research at LSU Health Sciences Center New Orleans' School of Dentistry, is the lead principal investigator of a $2.76 million grant from the National Institute of Dental and Craniofacial Research over five years to study how HIV and antiretroviral therapy may change communities of bacteria in the mouth and what effects those changes may have on oral infections in HIV disease.

CIGNA reports consolidated revenues of $4.5 billion for the third quarter of 2009

CIGNA Corporation today reported shareholders' net income of $329 million, or $1.19 per share, for the third quarter of 2009 compared with shareholders' net income of $171 million, or $0.62 per share, for the same period last year. Shareholders' net income for the third quarter 2009 included income related to the variable annuity products within our Run-off Reinsurance segment of $16 million after-tax, or $0.06 per share, primarily related to favorable performance in the equity markets.

New program combines basic science and social benefits to address HIV risk among young women

A program established by investigators from the Ragon Institute of Massachusetts General Hospital, MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from two angles - first, investigating biological factors that modulate infection risk along with the early immunologic events following viral exposure, and second, alleviating the socioeconomic factors that limit opportunities for young women, the group at greatest risk of infection in the region of the world hardest hit by the HIV epidemic.

OriGene releases 1,500 mouse monoclonal antibodies

OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand. Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and diagnostic needs requiring improved antibody sensitivity and specificity.

Read more Medical News

› Verified 3 days ago

• 1(current)
• 2
• 3
• 4
• 5